Profile data is unavailable for this security.
About the company
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.
- Revenue in USD (TTM)447.48m
- Net income in USD-14.55m
- Incorporated2001
- Employees1.02k
- LocationAccuray Inc1240 DEMING WAYMADISON 53717United StatesUSA
- Phone+1 (608) 824-2800
- Fax+1 (408) 716-4601
- Websitehttps://www.accuray.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Butterfly Network Inc | 65.90m | -133.70m | 146.69m | 225.00 | -- | 0.6651 | -- | 2.23 | -0.6507 | -0.6507 | 0.3209 | 1.06 | 0.1826 | 0.7376 | 4.69 | 292,888.90 | -37.04 | -- | -42.70 | -- | 25.58 | -- | -202.88 | -- | 3.57 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
| Inogen Inc | 315.66m | -102.45m | 152.58m | 834.00 | -- | 0.738 | -- | 0.4834 | -4.42 | -4.42 | 13.62 | 8.78 | 0.8634 | 6.76 | 6.01 | 378,489.20 | -28.02 | -8.23 | -34.53 | -9.53 | 40.14 | 44.54 | -32.46 | -10.31 | 2.56 | -- | 0.00 | -- | -16.32 | -2.49 | -22.30 | -- | 26.34 | -- |
| Orchestra Biomed Holdings Inc | 2.76m | -49.12m | 158.85m | 56.00 | -- | 2.33 | -- | 57.55 | -1.49 | -1.49 | 0.0832 | 1.90 | 0.0289 | 0.8815 | 28.31 | 49,285.71 | -51.49 | -- | -61.01 | -- | 93.26 | -- | -1,779.71 | -- | 7.94 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| InfuSystem Holdings Inc | 125.79m | 872.00k | 161.82m | 499.00 | 192.03 | 3.08 | 12.05 | 1.29 | 0.0396 | 0.0396 | 5.86 | 2.47 | 1.24 | 11.17 | 6.85 | 252,074.10 | 0.8621 | 4.60 | 1.01 | 5.69 | 50.17 | 56.43 | 0.6933 | 4.07 | 1.54 | 1.88 | 0.3575 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
| Semler Scientific Inc | 68.18m | 20.58m | 182.18m | 92.00 | 9.86 | 2.48 | 8.60 | 2.67 | 2.63 | 2.63 | 8.71 | 10.43 | 0.9688 | 15.28 | 13.62 | 741,130.40 | 29.25 | 38.83 | 32.24 | 44.41 | 89.76 | 90.22 | 30.19 | 32.58 | 10.56 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
| Akoya Biosciences Inc | 96.63m | -63.32m | 187.72m | 330.00 | -- | 3.49 | -- | 1.94 | -1.48 | -1.48 | 2.18 | 1.09 | 0.5423 | 2.49 | 7.23 | 292,827.30 | -35.53 | -- | -44.59 | -- | 58.27 | -- | -65.53 | -- | 2.94 | -10.94 | 0.5882 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| Stereotaxis Inc | 26.77m | -22.06m | 193.00m | 122.00 | -- | 11.64 | -- | 7.21 | -0.2737 | -0.2737 | 0.3318 | 0.2708 | 0.5617 | 1.46 | 6.01 | 219,434.40 | -43.46 | -25.02 | -61.11 | -34.12 | 55.51 | 67.57 | -77.37 | -41.90 | 1.88 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| Accuray Inc | 447.48m | -14.55m | 216.19m | 1.02k | -- | 4.54 | -- | 0.4831 | -0.1496 | -0.1496 | 4.62 | 0.4806 | 0.9469 | 1.90 | 5.37 | 436,994.20 | -3.08 | -1.45 | -5.28 | -2.48 | 33.97 | 37.86 | -3.25 | -1.62 | 0.8406 | 0.3262 | 0.7857 | -- | 4.12 | 2.03 | -73.56 | -- | 13.92 | -- |
| Senseonics Holdings Inc | 22.39m | -60.39m | 221.99m | 132.00 | -- | 6.20 | -- | 9.91 | -0.1023 | -0.1023 | 0.0387 | 0.1385 | 0.1418 | 2.40 | 6.41 | 169,621.20 | -38.24 | -73.65 | -45.21 | -106.97 | 13.81 | -40.41 | -269.73 | -649.86 | 7.03 | -- | 0.3593 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
| AngioDynamics, Inc. | 324.01m | -192.37m | 231.52m | 815.00 | -- | 1.07 | -- | 0.7145 | -4.78 | -4.78 | 8.10 | 5.41 | 0.7468 | 2.66 | 6.46 | 397,555.80 | -44.34 | -9.12 | -54.02 | -10.17 | 50.17 | 54.23 | -59.37 | -19.48 | 1.62 | -- | 0.00 | -- | 7.13 | 5.30 | -97.54 | -- | 3.55 | -- |
| Utah Medical Products, Inc. | 50.22m | 16.64m | 237.92m | 169.00 | 14.49 | 1.88 | 10.37 | 4.74 | 4.57 | 4.57 | 13.81 | 35.35 | 0.3873 | 2.19 | 11.25 | 297,183.40 | 12.83 | 12.69 | 13.38 | 13.19 | 59.81 | 61.57 | 33.12 | 30.51 | 20.53 | -- | 0.00 | 37.05 | -3.93 | 3.64 | 0.9834 | 1.65 | 9.71 | 1.86 |
| Sight Sciences Inc | 81.06m | -55.55m | 254.70m | 214.00 | -- | 2.10 | -- | 3.14 | -1.14 | -1.14 | 1.67 | 2.45 | 0.4269 | 1.70 | 5.51 | 378,761.70 | -29.26 | -38.78 | -31.77 | -42.20 | 85.34 | 80.74 | -68.53 | -105.14 | 12.65 | -10.59 | 0.2201 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
| Edap Tms SA (ADR) | 64.83m | -22.72m | 275.39m | 307.00 | -- | 4.51 | -- | 4.25 | -0.6143 | -0.6143 | 1.75 | 1.65 | 0.6272 | 2.68 | 3.86 | 211,166.30 | -21.98 | -6.62 | -29.54 | -9.22 | 40.40 | 43.23 | -35.05 | -9.59 | 2.30 | -27.44 | 0.1045 | -- | 9.64 | 9.05 | -622.06 | -- | 32.75 | -- |
| Pulmonx Corp | 68.68m | -60.84m | 283.33m | 279.00 | -- | 2.38 | -- | 4.13 | -1.60 | -1.60 | 1.81 | 3.07 | 0.3698 | 1.14 | 6.61 | 246,147.00 | -32.76 | -26.27 | -36.90 | -28.97 | 73.90 | 71.95 | -88.60 | -93.76 | 5.77 | -- | 0.2394 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
| AxoGen Inc | 159.01m | -21.72m | 284.95m | 426.00 | -- | 2.94 | -- | 1.79 | -0.5070 | -0.5070 | 3.71 | 2.22 | 0.8108 | 1.63 | 6.72 | 373,267.60 | -11.07 | -13.92 | -12.85 | -15.84 | 78.46 | 79.74 | -13.66 | -20.28 | 2.14 | -- | 0.3277 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
Data as of Apr 25 2024. Currency figures normalised to Accuray Inc's reporting currency: US Dollar USD
39.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2023 | 6.91m | 6.97% |
| Archon Capital Management LLCas of 31 Dec 2023 | 6.51m | 6.57% |
| Neuberger Berman Investment Advisers LLCas of 31 Dec 2023 | 5.50m | 5.54% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 5.08m | 5.12% |
| Royce & Associates LPas of 31 Dec 2023 | 3.23m | 3.26% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 2.87m | 2.89% |
| Heartland Advisors, Inc.as of 31 Dec 2023 | 2.86m | 2.88% |
| Geode Capital Management LLCas of 31 Dec 2023 | 2.00m | 2.01% |
| D. E. Shaw & Co. LPas of 31 Dec 2023 | 1.92m | 1.93% |
| Harbert Fund Advisors, Inc.as of 31 Dec 2023 | 1.85m | 1.87% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
